ACA
KYMR icon

Avoro Capital Advisors’s Kymera Therapeutics KYMR Stock Holding History

Avoro Capital Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$857M Hold
7,474,747
– – 7.7% 7
2026
Q1 		$623M Hold
7,474,747
– – 6.12% 7
2025
Q4 		$582M Buy
7,474,747
+1,124,747
+18% +$76M 5.72% 7
2025
Q3 		$359M Sell
6,350,000
-205,555
-3% -$9.27M 4.65% 7
2025
Q2 		$286M Buy
6,555,555
+95,555
+1% +$3.29M 5.01% 6
2025
Q1 		$177M Buy
6,460,000
+1,310,000
+25% +$47.8M 2.76% 11
2024
Q4 		$207M Buy
5,150,000
+650,000
+14% +$29.4M 2.93% 14
2024
Q3 		$213M Buy
4,500,000
+611,112
+16% +$27M 3.11% 12
2024
Q2 		$116M Hold
3,888,888
– – 1.55% 18
2024
Q1 		$156M Buy
3,888,888
+113,888
+3% +$4.07M 1.82% 19
2023
Q4 		$96.1M Sell
3,775,000
-80,000
-2% -$1.43M 1.33% 18
2023
Q3 		$53.6M Hold
3,855,000
– – 0.84% 19
2023
Q2 		$88.6M Hold
3,855,000
– – 1.2% 18
2023
Q1 		$114M Buy
3,855,000
+5,000
+0.1% +$161K 1.69% 16
2022
Q4 		$96.1M Buy
3,850,000
+1,680,770
+77% +$44.8M 1.44% 17
2022
Q3 		$47.2M Buy
2,169,230
+909,230
+72% +$24M 0.87% 21
2022
Q2 		$24.8M Buy
1,260,000
+443,500
+54% +$10.4M 0.49% 28
2022
Q1 		$34.6M Buy
816,500
+266,500
+48% +$11.3M 0.63% 24
2021
Q4 		$34.9M Buy
550,000
+94,250
+21% +$5.49M 0.59% 27
2021
Q3 		$26.8M Buy
+455,750
New +$26.4M 0.42% 33
2020
Q4 		– Sell
-49,400
Closed -$1.6M – 47
2020
Q3 		$1.6M Buy
+49,400
New +$1.51M 0.02% 46

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Avoro Capital Advisors's KYMR Position: Q2 2026 in Review

Avoro Capital Advisors held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 7,474,747 shares worth $857M. The position accounts for 7.7% of the portfolio, ranked #7.

Avoro Capital Advisors first reported a position in KYMR in Q3 2020 and has held it in 21 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Avoro Capital Advisors held 7,474,747 shares of Kymera Therapeutics worth $857M as of Q2 2026.
  • Avoro Capital Advisors left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up 7.7% of Avoro Capital Advisors's portfolio in Q2 2026, its #7 holding.
  • Avoro Capital Advisors first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 21 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Avoro Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.